百日咳疫苗

Pertussis vaccine

未知生产厂商

Pertussis vaccine is under investigation in clinical trial NCT01698346 (Pertussis (Tdap) Vaccination in Pregnancy).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Pertussis vaccine is under investigation in clinical trial NCT01698346 (Pertussis (Tdap) Vaccination in Pregnancy).

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology
US 2012177688 A1申请人: LOCHT CAMILLE优先权: 2009
EP
US
10 件公开
TREATMENT AND PREVENTION OF NEUROPATHOLOGY ASSOCIATED WITH NEURODEGENERATIVE DISEASES
EP 4247397 A4申请人: ILIAD BIOTECHNOLOGIES LLC优先权: 2020
CN
EP
US
WO
8 件公开
SELF-ASSSEMBLING NANOSTRUCTURE VACCINES
EP 3758747 A1申请人: UNIV WASHINGTON优先权: 2018
CN
EP
US
WO
6 件公开
Multivalent vaccine composition
- EP 2279748 A1
  申请人: SMITHKLINE BEECHAM BIOLOG优先权: 2000
  CN
  EP
  US
  6 件公开
- US 11235054 B2
  申请人: SERUM INSTITUTE OF INDIA PVT LTD优先权: 2016
  CN
  US
  2 件公开
IPV-DPT vaccine
CN 105126095 A申请人: UNIV OSAKA RES FOUND优先权: 2006
CN
US
5 件公开
Therapeutic agent for cancer
US 9045556 B2申请人: UDAKA KEIKO优先权: 2007
CN
US
5 件公开
DIPHTHERIA-TETANUS-PERTUSSIS COMPOUND ADJUVANT COMBINED VACCINE
EP 4582097 A4申请人: CHANGCHUN BCHT BIOTECHNOLOGY CO优先权: 2022
CN
EP
US
WO
4 件公开
Combination vaccine with acellular pertussis
US 8551451 B2申请人: JAIN RAJESH优先权: 2008
CN
EP
US
4 件公开
Novel Recombinant Bordetella Strains
US 2015210978 A1申请人: INST NAT SANTE RECH MED优先权: 2012
CN
EP
US
4 件公开
Liquid six combined vaccine composition
US 12268738 B2申请人: KM BIOLOGICS CO LTD优先权: 2021
CN
EP
US
4 件公开